Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.

MLA

Fadini, Gian Paolo, et al. “Oral or Injectable Semaglutide for the Management of Type 2 Diabetes in Routine Care: A Multicentre Observational Study Comparing Matched Cohorts.” Diabetes, Obesity & Metabolism, vol. 26, no. 6, June 2024, pp. 2390–400. EBSCOhost, https://doi.org/10.1111/dom.15554.

APA

Fadini, G. P., Bonora, B. M., Ghiani, M., Anichini, R., Melchionda, E., Fattor, B., Fazion, S., Meregalli, G., Giaccari, A., Avogaro, A., Consoli, A., Baldassarre, M. A. P., Formoso, G., Leto, G., Leonetti, F., Zavattaro, M., Aimaretti, G., Barale, C., Cau, R., & Muscarà, A. (2024). Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, Obesity & Metabolism, 26(6), 2390–2400. https://doi.org/10.1111/dom.15554

Chicago

Fadini, Gian Paolo, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, et al. 2024. “Oral or Injectable Semaglutide for the Management of Type 2 Diabetes in Routine Care: A Multicentre Observational Study Comparing Matched Cohorts.” Diabetes, Obesity & Metabolism 26 (6): 2390–2400. doi:10.1111/dom.15554.